// App-Quantinova.ai

T1201 2016 AHA : IMPROVEDD Score: Addition of D-Dimer to the IMPROVE Score Improves Venous Thromboembolism Risk Stratification. An APEX Trial Substudy

Researchers

Presenter

  • Gerald Chi

Principal Investigators

  • Purva Jain

  • Donald Szlosek

  • Samuel Z Goldhaber

  • Russell D Hull

  • Adrian F Hernandez

  • Serge Korjian

  • Yazan Daaboul

  • Robert A Harrington

  • Alexander T Cohen

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

  • Univ of Calgary, Calgary, Canada

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Duke Clinical Research Institute, Durham, NC

  • Beth Israel Deaconess Medical Center, Boston, MA

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • Apurinic/Apyrimidinic Endodeoxyribonuclease 1

  • D-dimer

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved